News & Trends - Pharmaceuticals
Electronic prescriptions to support vulnerable Australians during COVID-19 outbreak

Pharma News: Pharmacists will be able to better support vulnerable patients following the Federal Government’s announcement to fund home medicines services as part of its $2.4 billion COVID-19 health package.
PSA National President Associate Professor Chris Freeman welcomed the Government’s announcement that $25 million will be allocated to fund home medicines services which will enable patients to have their PBS prescriptions filled online or remotely, and have their medicines delivered to their home.
These measures will support the announced telehealth Medicare items for GPs to help contain the spread of the virus and allow GPs to conduct consultations via phone or video.
“However, the effectiveness of this initiative will depend on the successful roll-out of electronic prescription which the Federal Government has committed an additional $5 million of funding to fast track software capability,” he said.
Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.
“PSA has been working with the Government to build capability for electronic prescriptions for many years. Fast-tracking of e-prescriptions is appropriate to ensure people in isolation are able to receive their essential and regular medicines to maintain their health.
PSA supports the approach in fast tracking electronic prescriptions but more needs to be done to support community pharmacy in the adoption and implementation of this initiative.
“This is particularly significant as we know that people with other health conditions, such as cardiovascular disease, are at higher risk of complications of COVID-19.”
Enhance corporate branding and boost thought leadership to attract and retain quality employees. How does your company culture measure up in the Australian Pharma industry? Get the benchmark report by contacting us.
Associate Professor Freeman welcomed the funding of home delivery services as a pragmatic measure to ensure those people unable to leave their homes were not out of pocket at a time they were more likely to be under increased financial stress
“PSA has been working closely with the Federal Government to highlight issues pharmacists on the frontline are experiencing in supporting their patients, including security of medicine supply, the availability of Personal Protective Equipment (PPE), stockpiling of medicines and the continuation of emergency dispensing provisions,” he said.
“We will continue to work with the Government and the Health Minister, Greg Hunt, to ensure the roll-out of these initiatives is practical, effective and well-communicated to the pharmacist workforce.
“PSA will continue to inform the profession the details of these initiatives as they are worked through with the Department of Health.
“Australians look to their pharmacists for their healthcare advice and as frontline health providers it is important that pharmacists are supported by Government so they can continue to provide care for their patients.”
You may also like Prime Minister allocates $2.4b health package to tackle coronavirus in Australia including telehealth in primary care
News & Trends - Pharmaceuticals

Government’s long-awaited response to The New Frontier report unveiled after two-year wait
Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]
MoreNews & Trends - Pharmaceuticals

Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’
Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]
MoreNews & Trends - Pharmaceuticals

AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years
Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]
More